# Serum Ferroptosis Biomarkers (GPX4, MDA) in Alopecia Areata

> **NCT07733063** · — · RECRUITING · sponsor: **Istanbul Training and Research Hospital** · enrollment: 156 (estimated)

## Conditions studied

- Alopecia Areata(AA)
- Alopecia Areata
- Alopecia Areata (& Ophiasis)
- Alopecia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07733063
- **Lead sponsor:** Istanbul Training and Research Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2026-12-01
- **Final completion:** 2027-01-01
- **Target enrollment:** 156 (ESTIMATED)
- **Last updated:** 2026-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07733063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07733063, "Serum Ferroptosis Biomarkers (GPX4, MDA) in Alopecia Areata". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07733063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*